Table 1.
Association between Tim-3 expression on TILs and clinicopathologic parameters.
Parameters | N (%) | Tim-3− TILs | Tim-3+ TILs | p value |
---|---|---|---|---|
Sex | ||||
Female | 67 (50) | 30 (44.8) | 38 (56.7) | 0.167 |
Male | 67 (50) | 38 (55.2) | 29 (43.3) | |
Age (years) | ||||
≤60 | 82 (67.7) | 38 (56.7) | 44 (65.7) | 0.287 |
>60 | 52 (32.3) | 29 (43.3) | 23 (34.3) | |
B symptom | ||||
Yes | 107 (86.2) | 55 (82.1) | 52 (77.6) | 0.518 |
No | 27 (13.8) | 12 (17.9) | 15 (22.4) | |
Clinical stage | ||||
I-II | 64 (47.8) | 38 (56.7) | 26 (38.8) | 0.038 |
III-IV | 70 (52.2) | 29 (43.3) | 41 (61.2) | |
IPI scores | ||||
0-2 | 95 (73.8) | 53 (79.1) | 42 (62.7) | 0.036 |
3-5 | 39 (26.2) | 14 (20.9) | 25 (37.3) | |
LDH | ||||
Normal | 82 (55.4) | 47 (70.1) | 35 (52.2) | 0.033 |
High | 52 (44.6) | 20 (29.9) | 32 (47.8) | |
Subtypes | ||||
GCB | 44 (32.8) | 22 (32.8) | 22 (32.8) | 1.000 |
Non-GCB | 76 (56.7) | 38 (56.7) | 38 (56.7) | |
Unclassified | 14 (10.4) | 7 (10.4) | 7 (10.4) |